Gaël Paul Hammer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gaël Paul Hammer has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Michel Mittelbronn
University of Luxembourg
6 shared publications - David S. Bouvier
National Center of Pathology (NCP), Laboratoire National de Santé (LNS), Dudelange, Luxembourg
4 shared publications - Naguib Mechawar
Douglas Mental Health University Institute
4 shared publications - Dominique Mirault
McGill University- Douglas Research Centre
3 shared publications - Félicia Jeannelle
National Center of Pathology (NCP), Laboratoire National de Santé (LNS)
3 shared publications Maria Blettner
University Medical Centre
3 shared publications
Latest Publications
- Open Access
Disease-specific tangle immunophenotypes distinguish hippocampal vulnerability in Alzheimer's disease and Parkinson's disease dementia
INTRODUCTION: Tau pathology typically occurs in Alzheimer's disease (AD), however is also frequently present in Parkinson's disease dementia (PDD) and Dementia with Lewy Bodies (DLB), yet its disease-specific signature is unclear. METHODS: Five tau, amyloid-β, α-synuclein and neuronal markers were analysed across hippocampal subfields in non-demented controls (CTLs), AD, PDD and DLB using multiplex immunohistochemistry, single-tangle classification and confocal imaging. RESULTS: AT8, pTau217, and GT38 were predominatly detected in AD, while pS422 was enriched in PDD and pS396 showed a region- and disease-specific pattern. DLB resembled AD in subregional tau distribution. Tau marker correlation were different comparing AD, PDD and CTL. Single-tangle analyses revealed disease-specific immunophenotypes but conserved mature intra-tangle epitope organisation. Distinct tau signatures were associated with inhibitory interneuron vulnerability, while regional tau co-occurrence with amyloid-β and α-synuclein remained conserved. DISCUSSION: Disease-specific tau signatures vary across hippocampal subregions and neuronal populations, implicating the contribution of regional and cell-specific factors beyond pathology burden.
Open AccessDisease-specific tangle immunophenotypes distinguish hippocampal vulnerability in Alzheimer's disease and Parkinson's disease dementia
INTRODUCTION: Tau pathology typically occurs in Alzheimer's disease (AD), however is also frequently present in Parkinson's disease dementia (PDD) and Dementia with Lewy Bodies (DLB), yet its disease-specific signature is unclear. METHODS: Five tau, amyloid-β, α-synuclein and neuronal markers were analysed across hippocampal subfields in non-demented controls (CTLs), AD, PDD and DLB using multiplex immunohistochemistry, single-tangle classification and confocal imaging. RESULTS: AT8, pTau217, and GT38 were predominatly detected in AD, while pS422 was enriched in PDD and pS396 showed a region- and disease-specific pattern. DLB resembled AD in subregional tau distribution. Tau marker correlation were different comparing AD, PDD and CTL. Single-tangle analyses revealed disease-specific immunophenotypes but conserved mature intra-tangle epitope organisation. Distinct tau signatures were associated with inhibitory interneuron vulnerability, while regional tau co-occurrence with amyloid-β and α-synuclein remained conserved. DISCUSSION: Disease-specific tau signatures vary across hippocampal subregions and neuronal populations, implicating the contribution of regional and cell-specific factors beyond pathology burden.
- Open Access
GPC5 expression highlights astrocytic heterogeneity and divergent hippocampal responses in Alzheimer’s and Parkinson’s Dementia
Astrocytes are central to central nervous system (CNS) homeostasis and memory consolidation. They also display remarkably heterogeneous morphological phenotypes, functions and molecular profiles between and within distinct regions of the human brain. Yet, their role in regional vulnerability in neurodegenerative diseases (NDDs) remains poorly understood. To elucidate this subregional heterogeneity of astrocytes in the hippocampus and parahippocampal cortex and its implication for neurodegeneration, we employed high-content neuropathology, integrating chromogenic immunohistochemistry (cIHC) and digital pathology, to map and quantify the expression of functional astrocytic markers (GFAP, ALDH1L1, AQP4, GPC5 and ALDH7A1) of healthy individuals, of patients with Alzheimer’s disease (AD) or Parkinson’s disease with dementia (PDD). We found that astrocytic markers followed distinct expression patterns in AD and PDD. In AD, GFAP was strongly reduced in specific hippocampal regions, whereas AQP4 was increased and GPC5 expression, although regionally stable, was locally associated with amyloid and tau pathology. In PDD, astrocytic responses were characterized by selective decreases in ALDH1L1 and ALDH7A1, with GFAP and GPC5 remaining largely unaffected. Notably, GFAP and GPC5 expression delineated distinct astrocytic subtypes that were differentially distributed across hippocampal subfields and showed specific responses to AD and PD pathologies. These findings provide new insights into the landscape of astrocytic heterogeneity in the human hippocampus and beyond, revealing disease- and region-specific astrocytic signatures. Importantly, they underscore the value of incorporating novel markers such as GPC5 to fully capture astrocytic diversity and to better understand astrocyte contributions to neurodegeneration.
Open AccessGPC5 expression highlights astrocytic heterogeneity and divergent hippocampal responses in Alzheimer’s and Parkinson’s Dementia
Astrocytes are central to central nervous system (CNS) homeostasis and memory consolidation. They also display remarkably heterogeneous morphological phenotypes, functions and molecular profiles between and within distinct regions of the human brain. Yet, their role in regional vulnerability in neurodegenerative diseases (NDDs) remains poorly understood. To elucidate this subregional heterogeneity of astrocytes in the hippocampus and parahippocampal cortex and its implication for neurodegeneration, we employed high-content neuropathology, integrating chromogenic immunohistochemistry (cIHC) and digital pathology, to map and quantify the expression of functional astrocytic markers (GFAP, ALDH1L1, AQP4, GPC5 and ALDH7A1) of healthy individuals, of patients with Alzheimer’s disease (AD) or Parkinson’s disease with dementia (PDD). We found that astrocytic markers followed distinct expression patterns in AD and PDD. In AD, GFAP was strongly reduced in specific hippocampal regions, whereas AQP4 was increased and GPC5 expression, although regionally stable, was locally associated with amyloid and tau pathology. In PDD, astrocytic responses were characterized by selective decreases in ALDH1L1 and ALDH7A1, with GFAP and GPC5 remaining largely unaffected. Notably, GFAP and GPC5 expression delineated distinct astrocytic subtypes that were differentially distributed across hippocampal subfields and showed specific responses to AD and PD pathologies. These findings provide new insights into the landscape of astrocytic heterogeneity in the human hippocampus and beyond, revealing disease- and region-specific astrocytic signatures. Importantly, they underscore the value of incorporating novel markers such as GPC5 to fully capture astrocytic diversity and to better understand astrocyte contributions to neurodegeneration.
- 11 March 2025
- Published by Wiley in Cytopathology
- Vol. 36 (3) , 250-258
Digital Cytology Combined With Artificial Intelligence Compared to Conventional Microscopy for Anal Cytology: A Preliminary Study
Introduction: Recent studies have shown that digital cytology (DC) coupled with artificial intelligence (AI) algorithms is a valid approach to the diagnosis of cervico‐vaginal lesions using liquid‐based cytology (LBC). We evaluated the use of these methods for anal LBC specimens.Methods: A series of 124 anal LBC slides previously diagnosed by conventional microscopy (CC) were reviewed with a DC/AI system that generated a gallery of images. Diagnoses based on the selected images, according to the 2014 Bethesda System for Reporting Cervical Cytology, were compared to CC.Results: Overall, CC and DC/AI approaches detected a similar number of abnormal (ASC‐US+) cases (63 and 62 cases, respectively). We observed an exact concordance between CC and DC in 70 (57.9%) cases, corresponding to a moderate agreement between the two approaches (κ = 0.41, p < 0.001). A moderate agreement (κ = 0.48, p < 0.001) was also found when positive cases were stratified into ‘low‐grade’ (ASC‐US, LSIL) and ‘high‐grade’ lesions (ASC‐H, HSIL). The DC/AI system detected more cases of higher severity (ASC‐H, HSIL: 9 and 2 cases, respectively) than CC (3 cases classified as HSIL).Conclusions: The number of ASC‐US+ cases detected by both systems was similar. The DC/AI system detected more cases of higher severity compared to the CC.
- 11 March 2025
- Published by Wiley in Cytopathology
- Vol. 36 (3) , 250-258
Digital Cytology Combined With Artificial Intelligence Compared to Conventional Microscopy for Anal Cytology: A Preliminary Study
Introduction: Recent studies have shown that digital cytology (DC) coupled with artificial intelligence (AI) algorithms is a valid approach to the diagnosis of cervico‐vaginal lesions using liquid‐based cytology (LBC). We evaluated the use of these methods for anal LBC specimens.Methods: A series of 124 anal LBC slides previously diagnosed by conventional microscopy (CC) were reviewed with a DC/AI system that generated a gallery of images. Diagnoses based on the selected images, according to the 2014 Bethesda System for Reporting Cervical Cytology, were compared to CC.Results: Overall, CC and DC/AI approaches detected a similar number of abnormal (ASC‐US+) cases (63 and 62 cases, respectively). We observed an exact concordance between CC and DC in 70 (57.9%) cases, corresponding to a moderate agreement between the two approaches (κ = 0.41, p < 0.001). A moderate agreement (κ = 0.48, p < 0.001) was also found when positive cases were stratified into ‘low‐grade’ (ASC‐US, LSIL) and ‘high‐grade’ lesions (ASC‐H, HSIL). The DC/AI system detected more cases of higher severity (ASC‐H, HSIL: 9 and 2 cases, respectively) than CC (3 cases classified as HSIL).Conclusions: The number of ASC‐US+ cases detected by both systems was similar. The DC/AI system detected more cases of higher severity compared to the CC.
- Open Access
- 15 February 2025
- Published by Springer Nature in Acta Neuropathologica
- Vol. 149 (1) , 1-24
Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus
In Alzheimer’s disease (AD), microglia form distinct cellular aggregates that play critical roles in disease progression, including Aβ plaque-associated microglia (PaM) and the newly identified coffin-like microglia (CoM). PaM are closely associated with amyloid-β (Aβ) plaques, while CoM are enriched in the pyramidal layer of the CA2/CA1 hippocampal subfields, where they frequently engulf neurons and associate with tau-positive tangles and phosphorylated α-synuclein. To elucidate the role of these microglial subtypes, we employed high-content neuropathology, integrating Deep Spatial Profiling (DSP), multiplex chromogenic immunohistochemistry and confocal microscopy, to comprehensively map and characterise their morphological and molecular signatures, as well as their neuropathological and astrocytic microenvironments, in AD and control post-mortem samples. PaM and PaM-associated astrocytes exhibited signatures related to complement system pathways, ErbB signalling, and metabolic and neurodegenerative processes. In contrast, CoM displayed markers associated with protein degradation and immune signalling pathways, including STING, TGF-β, and NF-κB. While no direct association between CD8 + T cells and either microglial type was observed, CD163 + perivascular macrophages were frequently incorporated into PaM. These findings provide novel insights into the heterogeneity of microglial responses, in particular their distinct interactions with astrocytes and infiltrating immune cells, and shed light on specific neurodegenerative hotspots and their implications for hippocampal deterioration in AD.
- 15 February 2025
- Published by Springer Nature in Acta Neuropathologica
- Vol. 149 (1) , 1-24
Open AccessMicroglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus
In Alzheimer’s disease (AD), microglia form distinct cellular aggregates that play critical roles in disease progression, including Aβ plaque-associated microglia (PaM) and the newly identified coffin-like microglia (CoM). PaM are closely associated with amyloid-β (Aβ) plaques, while CoM are enriched in the pyramidal layer of the CA2/CA1 hippocampal subfields, where they frequently engulf neurons and associate with tau-positive tangles and phosphorylated α-synuclein. To elucidate the role of these microglial subtypes, we employed high-content neuropathology, integrating Deep Spatial Profiling (DSP), multiplex chromogenic immunohistochemistry and confocal microscopy, to comprehensively map and characterise their morphological and molecular signatures, as well as their neuropathological and astrocytic microenvironments, in AD and control post-mortem samples. PaM and PaM-associated astrocytes exhibited signatures related to complement system pathways, ErbB signalling, and metabolic and neurodegenerative processes. In contrast, CoM displayed markers associated with protein degradation and immune signalling pathways, including STING, TGF-β, and NF-κB. While no direct association between CD8 + T cells and either microglial type was observed, CD163 + perivascular macrophages were frequently incorporated into PaM. These findings provide novel insights into the heterogeneity of microglial responses, in particular their distinct interactions with astrocytes and infiltrating immune cells, and shed light on specific neurodegenerative hotspots and their implications for hippocampal deterioration in AD.
- Open Access
- 31 March 2023
- Published by MDPI AG in Dentistry Journal
- Vol. 11 (4) , 92
Effects of Minocycline Hydrochloride as an Adjuvant Therapy for a Guided Bone Augmentation Procedure in The Rat Calvarium
This in vivo study reports the influence of minocycline-HCl administration on extra-skeletal bone generation in a Guided Bone Augmentation model, utilizing titanium caps placed on the intact as well as perforated calvaria of rats. The test group was administered 0.5 mg/mL minocycline-HCl with the drinking water, and the amount of bone tissue in the caps was quantified at three time points (4, 8 and 16 weeks). A continuously increased tissue fill was observed in all groups over time. The administration of minocycline-HCl as well as perforation of the calvaria increased this effect, especially with regard to mineralization. The strongest tissue augmentation, with 1.8 times that of the untreated control group, and, at the same time, the most mineralized tissue (2.3× over untreated control), was produced in the combination of both treatments, indicating that systemic administration of minocycline-HCl has an accelerating and enhancing effect on vertical bone augmentation.
- 31 March 2023
- Published by MDPI AG in Dentistry Journal
- Vol. 11 (4) , 92
Open AccessEffects of Minocycline Hydrochloride as an Adjuvant Therapy for a Guided Bone Augmentation Procedure in The Rat Calvarium
This in vivo study reports the influence of minocycline-HCl administration on extra-skeletal bone generation in a Guided Bone Augmentation model, utilizing titanium caps placed on the intact as well as perforated calvaria of rats. The test group was administered 0.5 mg/mL minocycline-HCl with the drinking water, and the amount of bone tissue in the caps was quantified at three time points (4, 8 and 16 weeks). A continuously increased tissue fill was observed in all groups over time. The administration of minocycline-HCl as well as perforation of the calvaria increased this effect, especially with regard to mineralization. The strongest tissue augmentation, with 1.8 times that of the untreated control group, and, at the same time, the most mineralized tissue (2.3× over untreated control), was produced in the combination of both treatments, indicating that systemic administration of minocycline-HCl has an accelerating and enhancing effect on vertical bone augmentation.
- Open Access
- 17 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12426
Effects of Low Intensity Pulsed Ultrasound Stimulation on the Temporal Dynamics of Irradiated Bone Tissue Healing: A Histomorphometric Study in Rabbits
The present study evaluated the influence of Low-Intensity Pulsed Ultrasound (LIPUS) on the regeneration processes of non-critical-size bone defects in irradiated and non-irradiated rabbit tibias. Bone defects were surgically created on both tibiae of six rabbits. The control group had no additional treatment. In one intervention group, one tibia was irradiated with 15 Gy in a single dose. A second group was treated with LIPUS, and a third with a combination of both treatments. The control samples showed 83.10% ± 17.79% of bone repair after 9 weeks, while the irradiated bone had regenerated significantly less during the same period (66.42% ± 29.36%). The LIPUS treatment on irradiated bones performed a 79.21% ± 21.07% bone fill and could not significantly improve the response compared to the non-treated irradiated specimens. However, LIPUS treatment on non-irradiated bone showed bone formations beyond the size defect (115.91% ± 33.69%), which was a highly significant increase when compared to the control group or any irradiated group. The application of ultrasound to healthy bone produced highly significant and enhanced bone formations with 36.70% more regenerated bone when compared to the same application on irradiated bone. LIPUS vibration stimuli may be considered as a promising complementary treatment approach in non-irradiated bone regeneration procedures to shorten the treatment and enhance bone healing. In irradiated bones, the effect of ultrasound application is less clear, and further studies are needed to refine the dynamics of the present results.
- 17 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12426
Open AccessEffects of Low Intensity Pulsed Ultrasound Stimulation on the Temporal Dynamics of Irradiated Bone Tissue Healing: A Histomorphometric Study in Rabbits
The present study evaluated the influence of Low-Intensity Pulsed Ultrasound (LIPUS) on the regeneration processes of non-critical-size bone defects in irradiated and non-irradiated rabbit tibias. Bone defects were surgically created on both tibiae of six rabbits. The control group had no additional treatment. In one intervention group, one tibia was irradiated with 15 Gy in a single dose. A second group was treated with LIPUS, and a third with a combination of both treatments. The control samples showed 83.10% ± 17.79% of bone repair after 9 weeks, while the irradiated bone had regenerated significantly less during the same period (66.42% ± 29.36%). The LIPUS treatment on irradiated bones performed a 79.21% ± 21.07% bone fill and could not significantly improve the response compared to the non-treated irradiated specimens. However, LIPUS treatment on non-irradiated bone showed bone formations beyond the size defect (115.91% ± 33.69%), which was a highly significant increase when compared to the control group or any irradiated group. The application of ultrasound to healthy bone produced highly significant and enhanced bone formations with 36.70% more regenerated bone when compared to the same application on irradiated bone. LIPUS vibration stimuli may be considered as a promising complementary treatment approach in non-irradiated bone regeneration procedures to shorten the treatment and enhance bone healing. In irradiated bones, the effect of ultrasound application is less clear, and further studies are needed to refine the dynamics of the present results.
- Open Access
Concomitant AD and DLB pathologies shape subfield microglia responses in the hippocampus
Hippocampal alteration is at the centre of memory decline in the most common age-related neurodegenerative diseases: Alzheimer’s disease (AD) and Dementia with Lewy Bodies (DLB). However, the subregional deterioration of the hippocampus differs between both diseases with more severe atrophy in the CA1 subfield of the AD patients. How AD and DLB-typical pathologies compose the various local microenvironment of the hippocampus across AD and DLB needs to be further explored to understand this process. Additionally, microglia responses could further impact the atrophy rate. Some studies suggest that microglia react differently according to the underlying neurodegenerative disorder. How microglia are transformed across hippocampal subfields in AD and DLB, and how their changes are associated with disease-typical pathologies remains to be determined. To these purposes, we performed a volumetric analysis of phospho-Tau (P-Tau), Amyloid-ß (Aß), and phospho-α-Synuclein (P-Syn) loads, quantified and classified microglia according to distinct morphological phenotypes using high-resolution confocal 3D microscopy of hippocampal CA1, CA3 and DG/CA4 subfields of late-onset AD (n=10) and DLB (n=8) as well as age-matched control samples (n=11). We found that each of the Tau, Aß and Synuclein pathologies followed a specific subregional distribution, relatively preserved across AD and DLB. P-Tau, Aß and P-Syn burdens were significantly exacerbated in AD, with Tau pathology being particularly severe in the AD CA1. P-Tau and P-Syn burdens were highly correlated across subfields and conditions (R2Spear = 0.79; P < 0.001) and result from a local co-distribution of P-Tau and P-Syn inclusions in neighbouring neurons, with only a low proportion of double-positive cells. In parallel, we assessed the changes of the microglia responses by measuring 16 morphological features of more than 35,000 individual microglial cells and classifying them into seven-distinct morphological clusters. We found microglia features- and clusters-variations subfield- and condition-dependent. Two of the seven morphological clusters, with more amoeboid and less branched forms, were identified as disease-enriched and found to be further increased in AD. Interestingly, some microglial features or clusters were associated with one but more often with a combination of two pathologies in a subfield-dependent manner. In conclusion, our study shows a multimodal association of the hippocampal microglia responses with the co-occurrence, distribution and severity of AD and DLB pathologies. In DLB hippocampi, pathological imprint and microglia responses follow AD trends but with lesser severity. Our study suggests that the increased pathological burdens of P-Tau and P-Syn and associated microglia alterations are involved in a more severe deterioration of the CA1 in AD as compared to DLB.
Open AccessConcomitant AD and DLB pathologies shape subfield microglia responses in the hippocampus
Hippocampal alteration is at the centre of memory decline in the most common age-related neurodegenerative diseases: Alzheimer’s disease (AD) and Dementia with Lewy Bodies (DLB). However, the subregional deterioration of the hippocampus differs between both diseases with more severe atrophy in the CA1 subfield of the AD patients. How AD and DLB-typical pathologies compose the various local microenvironment of the hippocampus across AD and DLB needs to be further explored to understand this process. Additionally, microglia responses could further impact the atrophy rate. Some studies suggest that microglia react differently according to the underlying neurodegenerative disorder. How microglia are transformed across hippocampal subfields in AD and DLB, and how their changes are associated with disease-typical pathologies remains to be determined. To these purposes, we performed a volumetric analysis of phospho-Tau (P-Tau), Amyloid-ß (Aß), and phospho-α-Synuclein (P-Syn) loads, quantified and classified microglia according to distinct morphological phenotypes using high-resolution confocal 3D microscopy of hippocampal CA1, CA3 and DG/CA4 subfields of late-onset AD (n=10) and DLB (n=8) as well as age-matched control samples (n=11). We found that each of the Tau, Aß and Synuclein pathologies followed a specific subregional distribution, relatively preserved across AD and DLB. P-Tau, Aß and P-Syn burdens were significantly exacerbated in AD, with Tau pathology being particularly severe in the AD CA1. P-Tau and P-Syn burdens were highly correlated across subfields and conditions (R2Spear = 0.79; P < 0.001) and result from a local co-distribution of P-Tau and P-Syn inclusions in neighbouring neurons, with only a low proportion of double-positive cells. In parallel, we assessed the changes of the microglia responses by measuring 16 morphological features of more than 35,000 individual microglial cells and classifying them into seven-distinct morphological clusters. We found microglia features- and clusters-variations subfield- and condition-dependent. Two of the seven morphological clusters, with more amoeboid and less branched forms, were identified as disease-enriched and found to be further increased in AD. Interestingly, some microglial features or clusters were associated with one but more often with a combination of two pathologies in a subfield-dependent manner. In conclusion, our study shows a multimodal association of the hippocampal microglia responses with the co-occurrence, distribution and severity of AD and DLB pathologies. In DLB hippocampi, pathological imprint and microglia responses follow AD trends but with lesser severity. Our study suggests that the increased pathological burdens of P-Tau and P-Syn and associated microglia alterations are involved in a more severe deterioration of the CA1 in AD as compared to DLB.
- 21 August 2020
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 40 (3) , 920-921
Reply to ‘Comment on: Baaken D, Hammer GP, Seidenbusch MC, Schneider K, Spix C, Blettner M, Pokora R and Lorenz E 2019 Second follow-up of a German cohort on childhood cancer after exposure to postnatal diagnostic x-ray J. Radiol. Prot. 39 1074–91’
- 21 August 2020
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 40 (3) , 920-921
Reply to ‘Comment on: Baaken D, Hammer GP, Seidenbusch MC, Schneider K, Spix C, Blettner M, Pokora R and Lorenz E 2019 Second follow-up of a German cohort on childhood cancer after exposure to postnatal diagnostic x-ray J. Radiol. Prot. 39 1074–91’
- 19 February 2020
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 77 (5) , 285-291
Cohort study of occupational cosmic radiation dose and cancer mortality in German aircrew, 1960–2014
Objectives To determine cancer mortality compared with the general population and to examine dose-response relationships between cumulative occupational radiation dose and specific cancer outcomes in the German aircrew cohort. Methods For a cohort of 26 846 aircrew personnel, standardised mortality ratios (SMR) were calculated. Dose-response analyses were carried out using Poisson regression to assess dose-related cancer risks for the period 1960–2014. Exposure assessment comprises recently available dose register data for all cohort members and newly estimated retrospective cabin crew doses for 1960–2003. Results SMR for all-cause, specific cancer groups and most individual cancers were reduced in all aircrew groups. The only increases were seen for brain cancer in pilots (n=23, SMR 2.01, 95% CI 1.15 to 3.28) and for malignant melanoma (n=10, SMR 1.88, 95% CI 0.78 to 3.85). Breast cancer mortality among female cabin crew was similar to the general population (n=71, SMR 1.06, 95% CI 0.77 to 1.44). Overall median cumulative effective dose was 34.2 mSv (max: 116 mSv) for 1960–2014. No dose-response associations were seen in any of the models. For brain cancer, relative risks were elevated across dose categories. An indicative negative trend with increasing dose category was seen for large intestine cancer in female cabin crew (n=23). Conclusions There was no evidence for significant dose-response patterns for the considered cancer types. Interpretation of results remains difficult as cumulative dose is closely related to age. Future work should focus on investigating radiation jointly with other risk factors that may contribute to risks for specific cancers among aircrew.
- 19 February 2020
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 77 (5) , 285-291
Cohort study of occupational cosmic radiation dose and cancer mortality in German aircrew, 1960–2014
Objectives To determine cancer mortality compared with the general population and to examine dose-response relationships between cumulative occupational radiation dose and specific cancer outcomes in the German aircrew cohort. Methods For a cohort of 26 846 aircrew personnel, standardised mortality ratios (SMR) were calculated. Dose-response analyses were carried out using Poisson regression to assess dose-related cancer risks for the period 1960–2014. Exposure assessment comprises recently available dose register data for all cohort members and newly estimated retrospective cabin crew doses for 1960–2003. Results SMR for all-cause, specific cancer groups and most individual cancers were reduced in all aircrew groups. The only increases were seen for brain cancer in pilots (n=23, SMR 2.01, 95% CI 1.15 to 3.28) and for malignant melanoma (n=10, SMR 1.88, 95% CI 0.78 to 3.85). Breast cancer mortality among female cabin crew was similar to the general population (n=71, SMR 1.06, 95% CI 0.77 to 1.44). Overall median cumulative effective dose was 34.2 mSv (max: 116 mSv) for 1960–2014. No dose-response associations were seen in any of the models. For brain cancer, relative risks were elevated across dose categories. An indicative negative trend with increasing dose category was seen for large intestine cancer in female cabin crew (n=23). Conclusions There was no evidence for significant dose-response patterns for the considered cancer types. Interpretation of results remains difficult as cumulative dose is closely related to age. Future work should focus on investigating radiation jointly with other risk factors that may contribute to risks for specific cancers among aircrew.
- 18 October 2019
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 39 (4) , 1041-1059
Ionising radiation and lens opacities in interventional physicians: results of a German pilot study
We assessed the feasibility of an epidemiological study on the risk of radiation-related lens opacities among interventional physicians in Germany. In a regional multi-centre pilot study associated with a European project, we tested the recruitment strategy, a European questionnaire on work history for the latter dosimetry calculation and the endpoint assessment. 263 interventional physicians and 129 non-exposed colleagues were invited. Questionnaires assessed eligibility criteria, risk factors for cataract, and work history relating to occupational exposure to ionising radiation, including details on type and amount of procedures performed, radiation sources, and use of protective equipment. Eye examinations included regular inspection by an ophthalmologist, digital slit lamp images graded according to the lens opacities classification system, and Scheimpflug camera measurements. 46 interventional (17.5%) and 30 non-exposed physicians (23.3%) agreed to participate, of which 42 and 19, respectively, met the inclusion criteria. Table shields and ceiling suspended shields were used as protective equipment by 85% and 78% of the interventional cardiologists, respectively. However, 68% of them never used lead glasses. More, although minor, opacifications were diagnosed among the 17 interventional cardiologists participating in the eye examinations than among the 18 non-exposed (59% versus 28%), mainly nuclear cataracts in interventional cardiologists and cortical cataracts in the non-exposed. Opacification scores calculated from Scheimpflug measurements were higher among the interventional cardiologists, especially in the left eye (56% versus 28%). Challenges of the approach studied include the dissuading time investment related to pupil dilatation for the eye examinations, the reliance on a retrospective work history questionnaire to gather exposure-relevant information for dose reconstructions and its length, resulting in a low participation rate. Dosimetry data are bound to get better when the prospective lens dose monitoring as foreseen by 2013 European Directives is implemented and doses are recorded.
- 18 October 2019
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 39 (4) , 1041-1059
Ionising radiation and lens opacities in interventional physicians: results of a German pilot study
We assessed the feasibility of an epidemiological study on the risk of radiation-related lens opacities among interventional physicians in Germany. In a regional multi-centre pilot study associated with a European project, we tested the recruitment strategy, a European questionnaire on work history for the latter dosimetry calculation and the endpoint assessment. 263 interventional physicians and 129 non-exposed colleagues were invited. Questionnaires assessed eligibility criteria, risk factors for cataract, and work history relating to occupational exposure to ionising radiation, including details on type and amount of procedures performed, radiation sources, and use of protective equipment. Eye examinations included regular inspection by an ophthalmologist, digital slit lamp images graded according to the lens opacities classification system, and Scheimpflug camera measurements. 46 interventional (17.5%) and 30 non-exposed physicians (23.3%) agreed to participate, of which 42 and 19, respectively, met the inclusion criteria. Table shields and ceiling suspended shields were used as protective equipment by 85% and 78% of the interventional cardiologists, respectively. However, 68% of them never used lead glasses. More, although minor, opacifications were diagnosed among the 17 interventional cardiologists participating in the eye examinations than among the 18 non-exposed (59% versus 28%), mainly nuclear cataracts in interventional cardiologists and cortical cataracts in the non-exposed. Opacification scores calculated from Scheimpflug measurements were higher among the interventional cardiologists, especially in the left eye (56% versus 28%). Challenges of the approach studied include the dissuading time investment related to pupil dilatation for the eye examinations, the reliance on a retrospective work history questionnaire to gather exposure-relevant information for dose reconstructions and its length, resulting in a low participation rate. Dosimetry data are bound to get better when the prospective lens dose monitoring as foreseen by 2013 European Directives is implemented and doses are recorded.